組織蛋白酶K(CTSK)重組蛋白
Recombinant Cathepsin K (CTSK)
CTS-K; CTS02; CTSO; CTSO1; CTSO2; PKND; PYCD; Pycnodysostosis; Cathepsin O; Cathepsin X
- 編號RPA267Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位溶酶體
- 預(yù)測分子量32.9kDa
- 實際分子量33kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Leu54~Ala317 with N-terminal His Tag
- 緩沖液成份100mM NaHCO3, 500mM NaCl緩沖液（pH8.3,含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點8.5
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1099 ¥ 2748 ¥ 5496 ¥ 16488 ¥ 41220
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA267Hu01 | 組織蛋白酶K(CTSK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA267Hu02 | 組織蛋白酶K(CTSK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA267Hu01 | 組織蛋白酶K(CTSK)多克隆抗體 | WB; ICC; IHC-P; IHC-F; ELISA. |
| PAA267Hu02 | 組織蛋白酶K(CTSK)多克隆抗體 | WB; IHC; ICC; IP. |
| MAA267Hu22 | 組織蛋白酶K(CTSK)單克隆抗體 | WB |
| MAA267Hu21 | 組織蛋白酶K(CTSK)單克隆抗體 | WB |
| LAA267Hu72 | 組織蛋白酶K(CTSK)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA267Hu | 組織蛋白酶K(CTSK)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA267Hu | 組織蛋白酶K(CTSK)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA267Hu01 | 組織蛋白酶K(CTSK)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA267Hu01 | 組織蛋白酶K(CTSK)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Acta Histochemica | MRMT-1 rat breast carcinoma cells and models of bone metastases: improvement of an in vitro system to mimic the in vivo condition. [PubMed: S0065128112000773] |
| Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery [Pubmed:24534452] |
| Genet. Mol. Res | Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats [Pubmed:25036175] |
| Age (Dordr) | In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes [PubMed: 26250906] |
| Journal of Infectious Diseases | Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis [PubMed: 26416658] |
| PLoS One. | Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis [pmc:PMC4822855] |
| Cell?Death?And Differentiation | TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42 [Pubmed:29358671] |
| Indian Journal of Dental Research | Comparative evaluation of cathepsin K levels in gingival crevicular fluid among smoking and nonsmoking patients with chronic periodontitis [Pubmed: 30409937] |
| International Journal of Biological Macromolecules | A bioactive exopolysaccharide from marine bacteria Alteromonas sp. PRIM-28 and its role in cell proliferation and wound healing in vitro [Pubmed: 30851325] |
| 畢業(yè)論文 | Biomarkers of Compromised Implant Fixation [] |
| neuroscience letters | Compound K induces neurogenesis of neural stem cells in thrombin induced nerve injury through LXRα signaling in mice [Pubmed: 32371156] |
| Информационный алгоритм неинвазивной оценки остеорезорбтивного побочного действия глюкокортикостероидов у больных язвенным колитом [] | |
| Особенности остеоиммунологических аспектов остеорезорбции при периимплантите, хроническом пародонтите и раке альвеолярного отростка и?… [] |
留言咨詢
